Anika to Issue Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights on Thursday, February 21
February 07 2019 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the
Company plans to issue its fourth-quarter and full-year 2018
financial results after the close of the market on Thursday,
February 21, 2019 and hold its investor conference call on the same
day, Thursday, February 21, 2019, at 5:00 p.m. ET to discuss its
financial results, business highlights, and outlook.
The conference call can be accessed by dialing 1-855-468-0611
(toll-free domestic) or 1-484-756-4332 (international). A live
audio webcast will be available in the "Investor Relations" section
of Anika's website, www.anikatherapeutics.com. An accompanying
slide presentation also can be accessed via the Anika Therapeutics
website. The call will be archived and accessible on the same
website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated orthopedic and regenerative medicines company based
in Bedford, Massachusetts. Anika is committed to
improving the lives of patients with degenerative orthopedic
diseases and traumatic conditions with clinically meaningful
therapies along the continuum of care, from palliative pain
management to regenerative tissue repair. The Company has over two
decades of global expertise developing, manufacturing, and
commercializing more than 20 products based on its
proprietary hyaluronic acid (HA) technology. Anika's
orthopedic medicine portfolio includes ORTHOVISC®, MONOVISC®, and
CINGAL®,which alleviate pain and restore joint function by
replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold
to aid cartilage repair and regeneration. For more information
about Anika, please visit www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190207005040/en/
For Investor Inquiries:Anika Therapeutics, Inc.Sylvia Cheung,
781-457-9000Chief Financial OfficerFor Media Inquiries:W2O
GroupSonal Vasudev, 917-523-1418sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024